BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18463397)

  • 1. Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis.
    Chen H; Lee JS; Liang X; Zhang H; Zhu T; Zhang Z; Taylor ME; Zahnow C; Feigenbaum L; Rein A; Sukumar S
    Cancer Res; 2008 May; 68(10):3637-44. PubMed ID: 18463397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
    Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
    Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
    Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
    Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
    McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
    Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.
    Jäger R; Friedrichs N; Heim I; Büttner R; Schorle H
    Breast Cancer Res Treat; 2005 Apr; 90(3):273-80. PubMed ID: 15830141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice.
    Pierpaoli E; Viola V; Barucca A; Orlando F; Galli F; Provinciali M
    Carcinogenesis; 2013 Jun; 34(6):1352-60. PubMed ID: 23430951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
    Provinciali M; Re F; Donnini A; Orlando F; Bartozzi B; Di Stasio G; Smorlesi A
    Int J Cancer; 2005 May; 115(1):36-45. PubMed ID: 15688416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.
    Li B; Rosen JM; McMenamin-Balano J; Muller WJ; Perkins AS
    Mol Cell Biol; 1997 Jun; 17(6):3155-63. PubMed ID: 9154814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis.
    Tekmal RR; Nair HB; Perla RP; Kirma N
    J Steroid Biochem Mol Biol; 2007; 106(1-5):111-8. PubMed ID: 17604617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
    Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice.
    Huang S; Chen Y; Podsypanina K; Li Y
    Neoplasia; 2008 Feb; 10(2):118-24. PubMed ID: 18283333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
    Podsypanina K; Li Y; Varmus HE
    BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.
    Huang S; Podsypanina K; Chen Y; Cai W; Tsimelzon A; Hilsenbeck S; Li Y
    Technol Cancer Res Treat; 2006 Dec; 5(6):565-71. PubMed ID: 17121432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma.
    Yuan W; Zhang X; Xu Y; Li S; Hu Y; Wu S
    Mol Carcinog; 2014 Jan; 53(1):49-57. PubMed ID: 22911672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone.
    Yee LD; Young DC; Rosol TJ; Vanbuskirk AM; Clinton SK
    J Nutr; 2005 May; 135(5):983-8. PubMed ID: 15867269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
    Anisimov VN; Khavinson VK; Provinciali M; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Imyanitov EN; Mancini R; Franceschi C
    Int J Cancer; 2002 Sep; 101(1):7-10. PubMed ID: 12209581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression.
    Cuello-Carrión FD; Cayado-Gutiérrez N; Natoli AL; Restall C; Anderson RL; Nadin S; Alvarez-Olmedo D; Castro GN; Gago FE; Fanelli MA; Ciocca DR
    Cell Stress Chaperones; 2013 Sep; 18(5):559-67. PubMed ID: 23397229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
    Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA
    Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
    Strumane K; Rygiel T; van der Valk M; Collard JG
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effect of alpha-bisabolol, a nontoxic sesquiterpene alcohol, on the induction of spontaneous mammary tumors in HER-2/neu transgenic mice.
    Costarelli L; Malavolta M; Giacconi R; Cipriano C; Gasparini N; Tesei S; Pierpaoli S; Orlando F; Suzuki H; Perbellini L; Piacenza F; Emanuelli M; Mocchegiani E
    Oncol Res; 2010; 18(9):409-18. PubMed ID: 20524399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.